News

Zynext Ventures USA LLC today announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage ...
Virtual Meeting to be held on April 23 hosted by Lake Street. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with ...
Detailed price information for Cardiol Therapeutics (CRDL-Q) from The Globe and Mail including charting and trades.
Paper co-lead author Phoolwanti Rani, a postdoctoral scholar in the Villa Lab ... Doudna is a cofounder of Azalea Therapeutics, Caribou Biosciences, Editas Medicine, Scribe Therapeutics, Intellia ...
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS ...
Talat Imran; Chief Executive Officer, Director; Rani Therapeutics Holdings Inc Svai Sanford; Chief Financial Officer; Rani Therapeutics Holdings Inc Welcome to the Rani fourth-quarter and full ...
Talat Imran; Chief Executive Officer, Director; Rani Therapeutics Holdings Inc Svai Sanford; Chief Financial Officer; Rani Therapeutics Holdings Inc Welcome to the Rani fourth-quarter and full-year ...
March 31, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics ...